Recently, the CRISPR/Cas9 mediated Bach1 knockout in a pancreatic cancer cell line (AsPC1) shows novel Bach1 targeted genes such as CLDN3, CLDN4, PKP2, CHD1, and FOXA1, a subset of genes that enhance the metastasis of tumor cells [209]. The gene discussed is BACH1; the disease is neoplasm.